EAM
NXTM

Eagle Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Eagle Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,573,603
Closed -$64.5M – 663
2017
Q2 		$64.5M Buy
2,573,603
+540,103
+27% +$13.4M 0.39% 80
2017
Q1 		$54.6M Buy
+2,033,500
New +$56.2M 0.34% 87

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eagle Asset Management's NXTM Position: Q3 2017 in Review

Eagle Asset Management sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 2,573,603 shares — an estimated $64.5M sold.

Eagle Asset Management first reported a position in NXTM in Q1 2017 and held it in 2 quarters. The position peaked at $64.5M in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Eagle Asset Management reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Eagle Asset Management sold 2,573,603 NxStage Medical Inc. shares in Q3 2017, an estimated $64.5M.
  • Eagle Asset Management first reported a position in NxStage Medical Inc. in Q1 2017 and held it in 2 quarters.
  • Eagle Asset Management's NxStage Medical Inc. position peaked at $64.5M in Q2 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Eagle Asset Management's 13F filing for Q3 2017, filed 9 Nov 2017.